Topic Archives: Genentech

Conflict Diamonds

[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and more recent comments here.] Picture the gurbling fumaroles of Yellowstone: from the late 1990’s and on into […]

What’s Happening in Cancer Treatment? Are We Making Progress, or Are We Stuck?

Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]

Comments

  • JohnM

    Thin-skinned with anger issues, yes. Don't know what "man-child" means. Con artist? No way. I've been investing in biote...

  • Avatar

    $DNLI Any thoughts in here about Denali? I've been following it for a year or so waiting for the IPO. I always loved Gen...

  • Avatar

    $ HALO LONG Halozyme Therapeutics (HALO) announces the initiation of a multi-arm clinical trial evaluating PEGPH20,...

  • SoGiAm

    $MRK & much more... NEW http://e.endpointsnews.com/t/ViewEmail/t/A537ED71EDB429B5/2F80028A944F69C925D77A725F39070E...

  • JohnM

    $best bio CEOs - I would LOVE to have you start a discussion on this topic. I've been investing in biotech since the Gen...

  • Avatar

    I too missed the Dr. exiting..I did call the firm and they do have a back up plan just in case it is needed..the managem...

  • Avatar

    I can't share any experience with that particular newsletter (I despise $1500/year newsletters in general), but I can sh...

  • Michael Jorrin,

    From what I have read, Genentech is only now launching a Phase 1 study in their DLK inhibitor, GDC-0134. I have the ut...

  • Avatar

    I wrote today about a different Alzheimer's Disease drug being tested in mice, not the one Doc Gumshoe mentioned. It als...

  • SoGiAm

    $AXSM long - Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors http://phx.corporate-ir.net/phoenix...

  • JohnM

    $TGTX long, Genentech needs to protect $7 billion a year in Rituxan sales. It's bigger for them than Avastin. They can b...

  • Avatar

    $reph and $xene question/clarification; $reph has successfully completed both ph 3's and safety study, and will be s...

  • Avatar

    Thanks for kind words, I feel like a rat for doing it but I am going to send you an email, please ignore as you like wri...

  • Avatar

    Doc, jking and fellow Gummies: Fovista is dead. Final analysis of the two completed pivotal phase 3 studies of fovi...

  • Avatar

    Doc, there is another name that Rodman and Renshaw is also bullish on and you have made both positive and negative comme...

  • Avatar

    Genentech oncology head jumps ship to Bellicum as CEO: https://t.co/4r0RqVu2uM...

  • JohnM

    Andrew L. Salzman, M.D., Chief Executive Officer and Chief Medical Officer Dr. Salzman is a physician, scientist, inven...

  • Avatar

    Like this spot to enter IMDZ here after recent secondary. Doc if I recall you liked IMDZ platforms when we discussed th...

  • SoGiAm

    $BLRX today announced collaboration with Genentech, Phase 1b BL-8040 in combination with Atezolizumab, Genentech's anti...

  • Avatar

    Doc Kss, would you think this company Epic Science would be in direct competition with BIOC ? They have a impressive cli...

  • SoGiAm

    TGIF 1 more day....please let's stay focused. $tril vol off the charts last 3 days on strength. Maybe Uncle Irv gives u...

  • Avatar

    Interesting Article Genentech's Trojan horse destroys cocooned Staphylococcus aureus http://davidusharauli.blogspot.c...

  • sogiam

    Antibody Engineering & Therapeutics 2015 http://www.ibclifesciences.com/AntibodyEng/overview.xml A couple of audio cli...

  • Avatar

    Xenon (XENE) achieves milestone with Genentech partnership. http://finance.yahoo.com/news/xenon-pharmaceuticals-achieve...

  • Avatar

    The Biotech Book Shelf? Are you kidding me? What a great idea for a thread, Anamorph! Thanks for your wonderful post...

  • Anamorph

    I know there are Gummies who, like me, find Dr KSS's essays as valuable for the intellectual stimulation they provide as...

  • Avatar

    Genentech brain trust leaves company. http://www.forbes.com/sites/matthewherper/2015/05/14/former-genentech-researchers...

  • JohnM

    DR. KSS - I have been investing in biotech since Genentech came public and have for all those years read thousands of pr...

  • Avatar

    XENE: Xenon Pharmaceuticals Appoints Dr. Richard H. Scheller to Its Board of Directors BURNABY, British Columbia, Ma...

  • Avatar

    Michael, I have never read such an excellent synopsis of the current state of oncology research in all that time and le...

  • Dr. KSS, MD PhD

    To Joe Schelble: about Curis($CRIS). I could see this one running another 20- 25 percent from here over the near term. W...

  • Dr. KSS, MD PhD

    I'd meant to comment during this past very busy week about Newlink Genetics ($NLNK). If you saw it spike mightily this w...

  • Avatar

    Has anyone mentioned Immunogen? Been in a slow steady decline with a reversal today. I don't see any news. Just looks...

  • Avatar

    I did some DD on the Solazyme website and looking at some existing SA articles--it is a very intriguing story. The alga...

  • Avatar

    Thanks Eyedoc for your great sleuthing on Avalanche Bio. I would like to add that the CEO of this company, Tom Chalberg...

  • Avatar

    Google's Calico makes some important hires. An attempt to develop anti-aging treatments. http://www.fiercebiotech.com...

  • Avatar

    Thanks, Dr.KSS. This is not surprising. I know that this might give GILD longs a mild bit of PAT, so let me give it a li...

  • Avatar

    Senesco Announces New CEO SNTI announced the appointment of Ronald A. Martell as chief executive officer at the 2014 ...

  • Steve Morningthunder

    Perhaps this explains a bit of the interest: Agios brought Dr. Chris Bowden on board to oversee the company's clinica...

  • Avatar

    Did he tell what the Cancer drug he was pushing? Wonder if the company is Roche or Genentech?...

  • Avatar

    Bought SGEN at just over $12 a year ago. My wife is in the biotech field. Some highly regarded execs from Genentech are ...

  • Avatar

    I own shares of Sangamo Biosciences (SGMO). Sangamo is focused on the research and commercial development of engineered ...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch